Targeting Osteosarcopaenia and Multimorbidity for Frailty Prevention
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age50+
SponsorTan Tock Seng Hospital
About this trial
The aging population and its accompanying burden from non-communicable chronic diseases predicts an increasing impact imposed by frailty on healthcare systems. This is due to a lack of normative data for older adults and reliable risk stratification methods to develop effective approaches to the prevention of frailty.
In this study, the investigators plan to form a common dataset for phenotype identification, risk stratification of frailty and its targeted treatment plans in the at-risk and mildly frail population.
Eligibility criteria
Qualifiers
Age ≥ 50y
Asian ethnicity
First diagnosis (stroke, Traumatic Brain Injury (TBI), knee osteoarthritis, breast cancer)
Living in community
Disqualifiers
Nursing home or dormitory resident
Non-resident status in Singapore (e.g. foreign worker, tourist, temporary visit pass)
Impairments affecting understanding of questionnaires and tasks: e.g. severe deafness, severe visual impairment and severe /global aphasia,
Presence of active fractures, dislocations, non-weight bearing status, burns, unhealed wounds, active skin infections/eczema and agitated behaviour or delirium
Trial design
Treatments tested in this trial
- Not listed
Trial groups
500 Participants
are grouped into 4 trial groupsSponsors and collaborators
Tan Tock Seng Hospital
Lead sponsor
Rehabilitation Research Institute of Singapore (RRIS)
Collaborator
Woodlands Health (WH)
Collaborator
Source ClinicalTrials.gov